(Q34945065)

5 August 2017

1 reference

title

Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis (English)

1 reference

cost-effectiveness analysis

5 August 2017

1 reference

1 reference

5

Pelham Barton

1 reference

5 August 2017

3

Paul Aveyard

1 reference

5 August 2017

Fujian Song

1

1 reference

5 August 2017

James Raftery

series ordinal

2

1 reference

5 August 2017

Chris Hyde

series ordinal

4

1 reference

5 August 2017

Nerys Woolacott

series ordinal

6

1 reference

5 August 2017

publication date

1 September 2002

1 reference

5 August 2017

published in

Medical Decision Making

1 reference

5 August 2017

volume

22

1 reference

5 August 2017

issue

5 Suppl

1 reference

5 August 2017

page(s)

S26-37

1 reference

Mortality in relation to smoking: 40 years' observations on male British doctors

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

Development of the health and economic consequences of smoking interactive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

Costs and effects associated with a community pharmacy-based smoking-cessation programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

The cost-effectiveness of the nicotine transdermal patch for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

The health care costs of smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

Economic implications of smoking cessation therapies: a review of economic appraisals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

Predicting smoking cessation. Who will quit with and without the nicotine patch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

Mortality in relation to smoking: 20 years' observations on male British doctors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence-and implications for coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

NICE: faster access to modern treatments? Analysis of guidance on health technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

Smoking and quitting with the aid of nicotine replacement therapies in the English adult population. Results from the Health Education Monitoring Survey 1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F027298902237708

21 January 2018

Identifiers

DOI

10.1177/027298902237708

1 reference

5 August 2017

1 reference